These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 7775839)

  • 1. Gastric carcinoma: recent issues in prognostic factors.
    Chen BF; Marrogi AJ; Freeman SM; Clejan S
    J La State Med Soc; 1995 Apr; 147(4):138-45. PubMed ID: 7775839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
    Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
    Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferating cell nuclear antigen, p53, and c-erbB-2 expression in relation to clinicopathological variables and prognosis in cancer of the ampulla of Vater.
    Ajiki T; Kamigaki T; Hasegawa Y; Fujino Y; Suzuki Y; Takeyama Y; Ku Y; Kuroda Y
    Hepatogastroenterology; 2001; 48(41):1266-70. PubMed ID: 11677943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of different biological markers (DNA index, PCNA index, apoptosis, p53, karyotype) in 126 adenocarcinoma gastric biopsies.
    Matturri L; Biondo B; Cazzullo A; Colombo B; Giordano F; Guarino M; Pallotti F; Turconi P; Lavezzi AM
    Anticancer Res; 1998; 18(4B):2819-25. PubMed ID: 9713468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of immunohistochemical staining for proliferating cell nuclear antigen, p53, and c-erbB-2 in sebaceous gland carcinoma and sweat gland carcinoma: comparison with histopathological parameter.
    Hasebe T; Mukai K; Yamaguchi N; Ishihara K; Kaneko A; Takasaki Y; Shimosato Y
    Mod Pathol; 1994 Jan; 7(1):37-43. PubMed ID: 7909154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationship between expressions of p53, c-erbB2 genes, proliferating cell nuclear antigen and prognosis of patients with ovarian epithelial carcinoma].
    Li JD; Li MD; Li YF; Huang X; Liu JH; Liu FY; Zhang CQ
    Ai Zheng; 2002 Mar; 21(3):292-6. PubMed ID: 12451998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. erbB-2 expression in well-differentiated adenocarcinoma of the stomach predicts shorter survival after curative resection.
    Motojima K; Furui J; Kohara N; Izawa K; Kanematsu T; Shiku H
    Surgery; 1994 Mar; 115(3):349-54. PubMed ID: 7907434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of the co-expression of p53 and c-erbB-2 proteins in breast cancer.
    Nakopoulou LL; Alexiadou A; Theodoropoulos GE; Lazaris AC; Tzonou A; Keramopoulos A
    J Pathol; 1996 May; 179(1):31-8. PubMed ID: 8691341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective analysis of the prognostic significance of DNA ploidy patterns in gastric cancer.
    Tirindelli Danesi D; Cucchiara G; Picconi A; Daffinà M; Fabiano A; Antonini F; Toscano MG; Pasqualetti P; Altavista P; Cordelli E; Spanò M
    Eur J Histochem; 1997; 41 Suppl 2():147-8. PubMed ID: 9859824
    [No Abstract]   [Full Text] [Related]  

  • 11. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PCNA and laminin as prognostic factors in primary Fallopian tube carcinoma.
    Hałoń A; Rabczyński J
    Folia Morphol (Warsz); 2003 Nov; 62(4):475-8. PubMed ID: 14655145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
    Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
    Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
    Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
    Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the prognostic value of a panel of tissue tumor markers and established clinicopathological factors in patients with gastric cancer.
    Wiksten JP; Lundin J; Nordling S; Kokkola A; Haglund C
    Anticancer Res; 2008; 28(4C):2279-87. PubMed ID: 18751407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Correlation of DNA ploidy, c-erbB-2 protein tissue status, level of PCNA expression and clinical outcome in gastric carcinomas].
    Takamura H; Yonemura Y; Hirono Y; Ninomiya I; Sahara H; Tsugawa K; Matsumoto H; Sugiyama K; Fujimura T; Nishimura G
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):788-95. PubMed ID: 8098198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
    Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
    Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
    Khalifa MA; Mannel RS; Haraway SD; Walker J; Min KW
    Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer.
    Logullo AF; Lopes AB; Nonogaki S; Soares FA; Netto MM; Nishimoto IN; Brentani MM
    Oncol Rep; 2007 Jul; 18(1):121-6. PubMed ID: 17549356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.